OS Fund explained

OS Fund
Type:Private
Foundation:2014
Founder:Bryan Johnson, Jeff Klunzinger
Location:Chicago
Products:Venture capital
Homepage:OSFund.co

OS Fund is an American venture capital fund that invests in early-stage science and technology companies.[1]

Firm

Bryan Johnson created OS Fund in October 2014, a year after selling Braintree to PayPal for $800 million.[2] He devoted $100 million from the sale to establishing the fund. Johnson and Jeff Klunzinger serve as the fund's general partners.[3] [4]

The fund draws its name from the acronym for operating system (OS), the software that underlies the basic functions of computers and provides a foundation for other applications. OS Fund focuses on investment in technologies and platforms in genomics, synthetic biology, computationally derived therapeutics, advanced materials, and diagnostics.[5]

In September 2015, OS Fund published the methodology it uses to evaluate investments in the field of synthetic biology. In order to promote the brand, Johnson said the fund publicly released the "playbook" on its website to encourage others to invest in emerging sciences.[6]

Origins

Johnson has said he launched the fund in response to a pullback in federal support of research and development,[3] and because of a general reluctance by more traditional venture capital firms to make science-related investments.[7]

Investments

OS Fund focuses on early-stage, computationally driven companies that utilize artificial intelligence and machine learning to develop platform technologies in genomics, synthetic biology, computationally derived therapeutics, advanced materials, and diagnostics.

Notable OS Fund investments include the following:

External links

Notes and References

  1. Web site: OS Fund LLC: Private Company Information. Bloomberg. 8 June 2015.
  2. Web site: Departed Braintree founder starts $100 million venture fund. Dameron. Emerson. October 21, 2014. Built In Chicago. 7 June 2015.
  3. Web site: Mims. Christopher. October 20, 2014. Humanity's Last Great Hope: Venture Capitalists. Wall Street Journal. 27 May 2021.
  4. Web site: About. OS Fund. 8 June 2015.
  5. Web site: Rewrite the OS, Change the World. Johnson. Bryan. October 20, 2014. Medium. 7 June 2015.
  6. Web site: Braintree Founder Unveils Open Source Playbook For Science Investors. Knapp. Alex. Forbes. September 15, 2015. October 8, 2015.
  7. Web site: Manifesto. OS Fund. 8 June 2015.
  8. Web site: Ginkgo Bioworks Raises $9M to 'Engineer' Food Flavors, Fragrances. Gormley. Brian. March 18, 2015. The Wall Street Journal. 8 June 2015.
  9. Web site: Why The First YC-Backed Biotech Company May Just Be The Future Of Pharma. Buhr. Sarah. TechCrunch. 8 June 2015.
  10. Ginkgo Bioworks Secures $45 Million from Viking Global, OS Fund, Y Combinator and Felicis Ventures. Boston. Business Wire. July 23, 2015. October 8, 2015.
  11. Web site: YC Alum Atomwise Raises $6 Million To Further The Advancement Of Artificial Intelligence In Drug Discovery. Buhr. Sarah. June 3, 2015. TechCrunch. October 8, 2015.
  12. Web site: Moving drug discovery into the fast lane: OS Fund invests in twoXAR's AI-driven approach. Klunzinger. Jeff. 2018-07-24. Medium. en. 2019-11-01.
  13. News: Castellanos. Sara. 2020-02-05. Where Computing Is Headed—Beyond Quantum. en-US. Wall Street Journal. 2020-05-25. 0099-9660.
  14. Web site: Crazy, insane start-ups are this tech investor's meat and potatoes. Mangalindan. JP. October 20, 2014. Fortune. 8 June 2015.